Clinical Trial Update: A Study of GEN1106 in Participants With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GEN1106 in solid tumors, with a focus on urothelial carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• GEN1106 (GEN1106)

Snippet

Sponsor: Genmab | Conditions: Solid Tumors, Urothelial Carcinoma | Phase 1 | Status: RECRUITING